Emalex Biosciences vs MapLight Therapeutics, Inc.
Emalex Biosciences
Improving people's lives impacted by central nervous system disorders through meaningful scientific breakthroughs
54 employees · est. 2018 · Chicago, United States
MapLight Therapeutics, Inc.
Creating breakthrough innovative therapeutics for serious CNS disorders
144 employees · est. 2018 · Redwood City, United States
Side-by-Side Comparison
| Metric | Emalex Biosciences | MapLight Therapeutics, Inc. |
|---|---|---|
| Founded | ||
| Founded | 2018 | 2018 |
| Headquarters | ||
| Headquarters | Chicago, United States | Redwood City, United States |
| Employees | ||
| Employees | 54 | 144 |
| Industry | ||
| Industry | Biopharma, Biotechnology, Health Care | Biopharma, Biotechnology, Life Sciences |
| Funding Stage | ||
| Funding Stage | Series D | Series C |
| Total Funding | ||
| Total Funding | $300.00M | $268.10M |
| Funding Rounds | ||
| Funding Rounds | 3 | 4 |
| Services | ||
| Services | Drug development for CNS disorders, Clinical research and trials, Expanded access program for investigational drugs | Discovery Platform Development, Innovative Therapeutic Development, Clinical Trials for CNS Conditions, Strategic Collaborations for New Treatments |
| Target Customers | ||
| Target Customers | Patients with Tourette syndrome, Healthcare providers specialized in CNS disorders, Tourette Syndrome community and advocacy groups | Patients with Brain Disorders, Healthcare Providers, Research Institutions, Investors in Biotechnology |
| Taxonomy | ||
| Taxonomy | Biotech StartupCentral Nervous System DisordersPharmaceutical InnovationBiopharmaceuticalsDrug DevelopmentTourette Syndrome Treatment +7 | BiopharmaceuticalInnovative TherapeuticsCNS DisordersCentral Nervous SystemDrug DiscoverySingle-cell Transcriptomics +8 |
| Website | ||
| Website | emalexbiosciences.com | maplightrx.com |
About Emalex Biosciences
Emalex Biosciences is a pioneering biotech company dedicated to enhancing lives through significant scientific innovations in the realm of central nervous system disorders. Established in 2018, this United States-based company is at the forefront of developing a novel drug class targeting Tourette s...
About MapLight Therapeutics, Inc.
MapLight Therapeutics, Inc., established in 2018, is a promising player in the biopharmaceutical arena, focused on developing breakthrough innovations for serious central nervous system (CNS) disorders. Known for its commitment to transformative therapies, the company's core mission aligns with its...
Also comparing in this category
We will tell you when either one moves
BounceWatch watches Emalex Biosciences and MapLight Therapeutics, Inc. for new funding, fast hiring, new executives and a change of software vendor. When one happens, it is in your next e-mail.
Get notified when Emalex Biosciences or MapLight Therapeutics, Inc. moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Frequently Asked Questions
Compare Emalex Biosciences with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Emalex Biosciences on 11 Mar 2026, and MapLight Therapeutics, Inc. on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
